medigraphic.com
SPANISH

Revista Médica MD

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 1

<< Back Next >>

Rev Med MD 2016; 7.8 (1)

Fulminant Liver Failure secondary to mushroom poisoning. A Case report and review

Sánchez-Guzmán S
Full text How to cite this article

Language: Spanish
References: 30
Page: 16-20
PDF size: 647.98 Kb.


Key words:

Amanita phalloides, intoxication, mushrooms, fulminant liver failure.

ABSTRACT

Mushroom poisoning is a rare reason for consultation in emergency medical services. In most cases, it is not possible to identify the type of mushroom consumed, which is why treatment should be guided based on the clinical spectrum. We present the case of a female who ate wild mushrooms during a ceremonial event in her community; she presented with acute liver failure and a characteristic prolonged latency period syndrome, probably caused by genus Amanita mushrooms.


REFERENCES

  1. 1.Nordt SP, 5 years analysis of mushroom exposures in California. West J Med. 2000; 173: 314-7.

  2. 2.Tintinalli J, et al. Medicina de urgencias. Sexta edición. Volumen II. Intoxicaciones por hongos. Mc Graw Hill, 2004. pp 1502-07.

  3. 3.Diaz JH. Envolving global epidemiology, sindromic classification, general management, and prevention of unknow mushroom poisonings. Crit Care Med 2005; 33(2): 419-26 .

  4. 4.Benitez-Macias JF. Intoxicaciones agudas por setas. Rev Clin Esp. 2009; 209 (11): 542-549.

  5. 5.Karlson-Stiber C, et al. Cytotoxic fungi – an overview. Toxicon. 2003; 42: 339-49.

  6. 6.Vetter J. Toxins of Amanita phalloides. Toxicon. 1998; 36: 13-24.

  7. 7.Broussard CN, et al. Mushroom poisoning-from diarrea to liver transplantation. Am J Gastroenterol. 2001; 56: 3195-8.

  8. 8.O'Grady JG, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989 Aug;97(2):439-45.

  9. 9.Diaz JH. Sindromic diagnosis and management of confirmed mushroom poisonings. Crit Care Med 2005; 33: 427-36.

  10. 10.Tong TC, et al. Comparative treatament of alphaamanitin poisoning with N-acetylcysteine, benzylpenicillin, cimetidine, thioctic acid, and sylibin in a murine model. Ann Emerg Med. 2007; 50: 282-8.

  11. 11.Catalina MV, et al. Toxicidad hepática por ingesta de setas: curso clínico y nuevas perspectivas de tratamiento. Gastroenterol Hepatol. 2003; 26: 417- 20.

  12. 12.Piqueras J. Hepatotoxic mushroom poisoning: diagnosis and management. Mycopathol. 1989; 105: 99-110.

  13. 13.Blackman JR. Clinical approach to toxic mushroom ingestión. J Am Board Fam Pract. 1994;7: 31-7.

  14. 14.Mykoweb. Mu shroom, fungi, mycology. Recuperado de: www.mykoweb.com/CAF.

  15. 1.Nordt SP, 5 years analysis of mushroom exposures in California. West J Med. 2000; 173: 314-7.

  16. 2.Tintinalli J, et al. Medicina de urgencias. Sexta edición. Volumen II. Intoxicaciones por hongos. Mc Graw Hill, 2004. pp 1502-07.

  17. 3.Diaz JH. Envolving global epidemiology, sindromic classification, general management, and prevention of unknow mushroom poisonings. Crit Care Med 2005; 33(2): 419-26 .

  18. 4.Benitez-Macias JF. Intoxicaciones agudas por setas. Rev Clin Esp. 2009; 209 (11): 542-549.

  19. 5.Karlson-Stiber C, et al. Cytotoxic fungi – an overview. Toxicon. 2003; 42: 339-49.

  20. 6.Vetter J. Toxins of Amanita phalloides. Toxicon. 1998; 36: 13-24.

  21. 7.Broussard CN, et al. Mushroom poisoning-from diarrea to liver transplantation. Am J Gastroenterol. 2001; 56: 3195-8.

  22. 8.O'Grady JG, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989 Aug;97(2):439-45.

  23. 9.Diaz JH. Sindromic diagnosis and management of confirmed mushroom poisonings. Crit Care Med 2005; 33: 427-36.

  24. 10.Tong TC, et al. Comparative treatament of alphaamanitin poisoning with N-acetylcysteine, benzylpenicillin, cimetidine, thioctic acid, and sylibin in a murine model. Ann Emerg Med. 2007; 50: 282-8.

  25. 11.Catalina MV, et al. Toxicidad hepática por ingesta de setas: curso clínico y nuevas perspectivas de tratamiento. Gastroenterol Hepatol. 2003; 26: 417- 20.

  26. 12.Piqueras J. Hepatotoxic mushroom poisoning: diagnosis and management. Mycopathol. 1989; 105: 99-110.

  27. 13.Blackman JR. Clinical approach to toxic mushroom ingestión. J Am Board Fam Pract. 1994;7: 31-7.

  28. 14.Mykoweb. Mu shroom, fungi, mycology. Recuperado de: www.mykoweb.com/CAF.

  29. 1.1.-OPS, OMS. Alerta Epidemiológica, Infección por virus Zika. Organización Panamericana de la Salud, Organización Mundial de la Salud [Internet].2015[Citado el 14 de Enero del 2016];1- 8.Disponible en: http://www.paho.org/hq/index.php?option=com_docman&task=doc_vie w&gid=30076&Itemid=27 0&lang=en

  30. 2.-OPS, OMS. Actualización Epidemiológica, Infección por virus Zika. Organización Panamericana de la Salud, Organización Mundial de la Salud [Internet].2015 [Citado el 14 de Enero del 2016];1-8. Disponible en: http://www.paho.org/hq/index.php?option=com_docman&task=doc_vie w&Itemid=270&gid=3202 3&lang




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med MD. 2016;7.8